TerraVia receives FDA GRAS no questions letter for algae butter
TerraVia Holdings has received a generally recognized as safe (GRAS) no questions letter from the U.S. Food and Drug Administration (FDA) for its algae butter.
TerraVia Holdings has received a generally recognized as safe (GRAS) no questions letter from the U.S. Food and Drug Administration (FDA) for its algae butter. This response paves the way for commercialization of this ingredient through its joint venture partner, Bunge North America.
Algae butter is a palm-free, non-hydrogenated, vegan solution for bakery, spreads, and confectionery applications. It is quick melting and provides clean taste while reducing saturated fat by up to 50% in most applications.
“The food industry has been searching for a replacement for palm and hydrogenated vegetable oils that maintains quality, taste, and functionality and that also meets their rigorous criteria for sustainable sourcing,” said Mark Brooks, senior vice president, TerraVia. “We believe algae butter is a game changer for the structuring fats industry in terms of sustainability and nutrition.”